Примери за използване на Post-hoc analysis на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
A post-hoc analysis was used to estimate the following public health outcomes against clinical CAP(as defined in the CAPiTA study,
In a post-hoc analysis of the combined dataset,
In a post-hoc analysis, lower mortality was observed in the lenalidomide/low dose dexamethasone arm 6.8%(15/220)
cohort studies, a post-hoc analysis of data from the MEDAL(Multinational Etoricoxib and Diclofenac Arthritis Long-term) programme,
It appeared from a post-hoc analysis of this study that, in the subgroup of patients with liver iron concentration≥7 mg Fe/g dw treated with deferasirox dispersible tablets(20
In particular, in a post-hoc analysis in 2,172 patients(17% of the total CURE population)
Post-hoc analysis of serious major adverse cardiovascular events(cardiovascular death,
In a post-hoc analysis in a subset of patients with HADS-anxiety or HADS-depression subscale scores≥8 at baseline(the cut-off value for anxiety or depression), a larger proportion of patients in the dupilumab 300 mg Q2W+ TCS and 300 mg QW+
In particular, in a post-hoc analysis in 2,172 patients(17% of the total CURE population)
In particular, in a post-hoc analysis in 2,172 patients(17% of the total CURE population)
thus reliability, of the post-hoc analysis of cardiovascular events during the Qsiva clinical development program remains a major concern, since with a total number of
In particular, in a post-hoc analysis in 2,172 patients(17% of the total CURE population)
which lead to conclusions based on post-hoc analysis that do not provide sufficient evidence to establish the efficacy for the use of sodium oxybate granules in the treatment of AWS.
Table 4- Post-hoc analyses excluding adjuvant patients a, b.
Table 4- Post-hoc analyses excluding adjuvant patientsa, b.
Table 9 Survival data from the primary analysis and post-hoc analyses.
Table 12 Survival data from the primary analysis and post-hoc analyses.
The results of these post-hoc analyses suggest increased clinical benefit for patients with two
Post-hoc analyses were performed to evaluate the impact of increased risk(number of risk factors) on clinical benefit(Table 8).
Further post-hoc analyses on mutations on RAS genes other than KRAS exon 2 have been evaluated.